Clinical Trial Update: Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 pilot trial evaluating motexafin gadolinium with high-dose methotrexate-based chemoimmunotherapy and radiation for newly diagnosed primary central ner…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Motexafin Gadolinium (motexafin gadolinium)

Snippet

Sponsor: Northwestern University | Conditions: Brain and Central Nervous System Tumors, Lymphoma | EARLY_Phase 1 | Status: WITHDRAWN